Oxford Asset Management’s Celgene Corp CELG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
Sell
-167,719
Closed -$16.7M 2293
2019
Q3
$16.7M Hold
167,719
0.4% 23
2019
Q2
$15.5M Hold
167,719
0.33% 37
2019
Q1
$15.8M Buy
167,719
+58,000
+53% +$5.07M 0.35% 35
2018
Q4
$7.03M Buy
109,719
+91,808
+513% +$6.78M 0.18% 135
2018
Q3
$1.6M Sell
17,911
-130,473
-88% -$11.5M 0.03% 788
2018
Q2
$11.8M Buy
148,384
+103,401
+230% +$8.59M 0.23% 67
2018
Q1
$4.01M Sell
44,983
-16,754
-27% -$1.61M 0.08% 247
2017
Q4
$6.45M Buy
61,737
+37,812
+158% +$4.27M 0.14% 167
2017
Q3
$3.49M Sell
23,925
-69,053
-74% -$9.41M 0.07% 347
2017
Q2
$12.1M Buy
92,978
+64,813
+230% +$7.94M 0.24% 45
2017
Q1
$3.5M Sell
28,165
-6,807
-19% -$815K 0.09% 234
2016
Q4
$4.05M Buy
+34,972
New +$3.89M 0.14% 138
2014
Q1
Sell
-141,524
Closed -$12M 912
2013
Q4
$12M Buy
+141,524
New +$11.2M 0.3% 71

Other funds holding CELG

Oxford Asset Management's CELG Position: Q4 2019 in Review

Oxford Asset Management sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 167,719 shares — an estimated $16.7M sold.

Oxford Asset Management first reported a position in CELG in Q4 2013 and held it in 13 quarters. The position peaked at $16.7M in Q3 2019. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.

  • Oxford Asset Management reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
  • Oxford Asset Management sold 167,719 Celgene Corp shares in Q4 2019, an estimated $16.7M.
  • Oxford Asset Management first reported a position in Celgene Corp in Q4 2013 and held it in 13 quarters.
  • Oxford Asset Management's Celgene Corp position peaked at $16.7M in Q3 2019.
  • 4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.

Based on Oxford Asset Management's 13F filing for Q4 2019, filed 13 Feb 2020.